Aetiology, diagnosis and management of infective causes of severe haemoptysis in intensive care units

Current Opinion in Pulmonary Medicine

Volumn 14, Issue 3, 2008, Pages 195-202

  Fartoukh, Muriel ^a   Parrot, Antoine ^a   Khalil, Antoine ^a  

^a HÔPITAL TENON   (France)

Author keywords

Alveolar haemorrhage; Mycetoma; Necrotizing pneumonia; Severe haemoptysis; Tuberculosis

Indexed keywords

ANTIBIOTIC AGENT; ANTIFUNGAL AGENT; PANTON VALENTINE LEUKOCIDIN; TUBERCULOSTATIC AGENT;

ANTIMICROBIAL THERAPY; ASPHYXIA; BACTERIAL ENDOCARDITIS; BACTERIAL PNEUMONIA; BLEEDING; BRONCHIAL ARTERY; BRONCHIECTASIS; BRONCHITIS; COMPUTER ASSISTED TOMOGRAPHY; DIAGNOSTIC IMAGING; DISEASE CONTROL; FALSE ANEURYSM; FIBEROPTIC BRONCHOSCOPY; GRAM STAINING; HEMOPTYSIS; HISTORY OF MEDICINE; HUMAN; IMMUNE DEFICIENCY; INFECTION; INTENSIVE CARE UNIT; INTERVENTION STUDY; LUNG ALVEOLUS; LUNG ASPERGILLOSIS; LUNG CANCER; LUNG FUNCTION; LUNG INFARCTION; LUNG LAVAGE; LUNG TUBERCULOSIS; MORBIDITY; MYCETOMA; MYCOBACTERIUM; NECROTIZING PARENCHYMAL INFECTION; PHYSICAL EXAMINATION; PHYSICIAN; PULMONARY ARTERY; PULMONARY ARTERY ANEURYSM; RADIOLOGY; RESPIRATORY SYSTEM; REVIEW; THORAX RADIOGRAPHY;

HEMOPTYSIS; HUMANS; INTENSIVE CARE; LUNG DISEASES; RESPIRATORY TRACT INFECTIONS;

EID: 42449151322     PISSN: 10705287     EISSN: 15316971     Source Type: Journal    
DOI: 10.1097/MCP.0b013e3282f79663     Document Type: Review

References (78)

1. Hakanson E, Konstantinov IE, Fransson SG, Svedjeholm R. Management of life-threatening haemoptysis. Br J Anaesth 2002; 88:291-295.
2. Jean-Baptiste E. Clinical assessment and management of massive hemoptysis. Crit Care Med 2000; 28:1642-1647.
3. Lordan JL, Gascoigne A, Corris PA. The pulmonary physician in critical care. Illustrative case 7: assessment and management of massive haemoptysis. Thorax 2003; 58:814-819.
4. Fartoukh M, Khalil A, Louis L, et al. An integrated approach to diagnosis and management of severe haemoptysis in patients admitted to the intensive care unit: a case series from a referral centre. Respir Res 2007; 8:11-20. Important clinical paper on the main causes and the management of severe haemoptysis requiring ICU admission.
5. Mal H, Rullon I, Mellot F, et al. Immediate and long-term results of bronchial artery embolization for life-threatening hemoptysis. Chest 1999; 115:996-1001.
6. Ong TH, Eng P. Massive hemoptysis requiring intensive care. Intensive Care Med 2003; 29:317-320.
7. Unsal E, Köksal D, Cimen F, et al. Analysis of patients with hemoptysis in a reference hospital for chest diseases. Tuberk Toraks 2006; 54:17-21.
8. Khalil A, Fartoukh M, Tassart M, et al. Role of MDCT in identification of the bleeding site and the vessels causing hemoptysis. AJR Am J Roentgenol 2007; 188:117-125. The role of MDCT in depicting the site as well as the cause and the mechanisms of bleeding is strengthened in this article.
9. Remy-Jardin M, Bouaziz N, Dumont P, et al. Bronchial and nonbronchial systemic arteries at multidetect row CT angiography: comparison with conventional angiography. Radiology 2004; 233:741-749.
10. Remy J, Arnaud A, Fardou H. Treatment of hemoptysis by embolization of bronchial arteries. Radiology 1977; 122:33-37.
11. Shin TB, Yoon SK, Lee KN, et al. The role of pulmonary CT angiography and selective pulmonary angiography in endovascular management of pulmonary artery pseudoaneurysms associated with infectious lung diseases. J Vasc Interv Radiol 2007; 18:882-887. Endovascular management of haemoptysis related to pulmonary artery pseudoaneurysms associated with infectious lung diseases is described.
12. Yoon YC, Lee KS, Jeong YJ, et al. Hemoptysis: bronchial and nonbronchial systemic arteries at detector row CT. Radiology 2005; 234:292-298.
13. Dweik RA, Stoller JK. Role of bronchoscopy in massive hemoptysis. Clin Chest Med 1999; 20:89-105.
14. Savale L, Parrot A, Khalil A, et al. Cryptogenic hemoptysis: from a benign to a life-threatening pathologic vascular condition. Am J Respir Crit Care Med 2007; 175:1181-1185.
15. McGuinness G, Beacher JR, Harkin TJ. Hemoptysis: prospective high resolution CT/bronchoscopic correlation. Chest 1994; 105:1155-1162.
16. Philpott NJ, Woodhead MA, Wilson AG, Millard FJ. Lung abscess: a neglected cause of life threatening haemoptysis. Thorax 1993; 48:674-675.
17. Lopez Alvarez JM, Valeron Lemaur ME, Consuegra Llapur E, et al. Lethal streptococcal toxic shock syndrome in pediatrics. Presentation of 3 cases. Med Intensiva 2007; 31:100-103.
18. Reimel BA, Krishnadasen B, Cuschieri J, et al. Surgical management of acute necrotizing lung infections. Can Respir J 2006; 13:369-373.
19. Pfitzner J, Peacock MJ, Tsirgiotis E, Walkley IH. Lobectomy for cavitating lung abscess with haemoptysis: strategy for protecting the controlateral lung and also the noninvolved lobe of the ipsilateral lung. Br J Anaesth 2000; 85:791-794.
20. Hamer DH, Schwab LE, Gray R. Massive hemoptysis from thoracic actinomycosis successfully treated by embolization. Chest 1992; 101:1442-1443.
21. Ayed A. Pulmonary resection for massive hemoptysis of benign etiology. Eur J Cardiothorac Surg 2003; 24:689-693.
22. Boussaud V, Parrot A, Mayaud C, et al. Life-threatening hemoptysis in adults with community-acquired pneumonia due to Panton-Valentine leukocidin-secreting Staphylococcus aureus. Intensive Care Med 2003; 29:1840-1843.
23. Gillet Y, Issartel B, Vanhems P, et al. Association between Staphylococcus aureus strains carrying gene for Panton-Valentine leukocidin and highly lethal necrotising pneumonia in young immunocompetent patients. Lancet 2002; 359:753-759.
24. Morgan MS. Diagnosis and treatment of Panton-Valentine leukocidin (PVL)-associated staphylococcal pneumonia. Int J Antimicrob Agents 2007; 30:289-296. This is a very interesting diagnostic and therapeutic overview of PVL-associated staphylococcal pneumonia.
25. Kravitz GR, Dries DJ, Peterson ML, Schlievert PM. Purpura fulminans due to Staphylococcus aureus. Clin Infect Dis 2005; 40:941-947.
26. Cuppen I, de Lange WCM, de Graaf SNN, et al. Broncholithiasis in an immune compromised boy with disseminated Mycobacterium kansasii. Pediatr Pulmonol 2007; 42:980-983.
27. Knott-Craig CJ, Oostuizen JD, Rossouw G. Management and prognosis of massive hemoptysis. J Thorac Cardiovasc Surg 1993; 105:394-397.
28. Ramakantan R, Bandekar VG, Gandhi MS. Massive hemoptysis due to pulmonary tuberculosis: control with bronchial artery embolization. Radiology 1996; 200:691-694.
29. Yeoh CB, Hubaytar RT, Ford JM, Wylie RH. Treatment of massive hemorrhage in pulmonary tuberculosis. J Thorac Cardiovasc Surg 1967; 54:503-510.
30. Reza B, Ziaollah H. Surgical management of tuberculous broncholithiasis with hemoptysis: experience with 5 operated cases. Ann Thorac Cardiovasc Surg 2007; 13:185-190. This is an interesting study reporting the experience of mild-to-severe haemoptysis related to tuberculous broncholithiasis, from clinical diagnosis to surgical resection.
31. Seo JB, Song KS, Lee JS, et al. Broncholithiasis: review of the causes with radiologic-pathologic correlation. Radiographics 2002; 22:S199-S213.
32. Stevens DA, Kan VL, Judson MA, et al. Practice guidelines for diseases caused by Aspergillus. Clin Infect Dis 2000; 30:696-709.
33. Uffredi ML, Mangiapan G, Cadranel J, Kac G. Significance of Aspergillus fumigatus isolation from respiratory specimens in nongranulocytopenic patients. Eur J Clin Microbiol Infect Dis 2003; 22:457-462.
34. Soubani AO, Chandrasekar PH. The clinical spectrum of pulmonary aspergillosis. Chest 2002; 121:1988-1999.
35. Faulkner SL, Vernon RW, Brown PP, et al. Hemoptysis and pulmonary aspergilloma: operative versus nonoperative treatment. Ann Thorac Surg 1978; 25:389-392.
36. Regnard JF, Icard P, Nicolosi M, et al. Aspergilloma: a series of 89 surgical cases. Ann Thorac Surg 2000; 69:898-903.
37. Dohen-Bécue F, Salez F, Ramon P, et al. Management of hemoptysis in invasive pulmonary aspergillosis. Rev Mal Respir 1998; 15:791-796.
38. Gorelik O. Fatal haemoptysis induced by invasive pulmonary aspergillosis in patients with acute leukaemia during bone marrow and clinical remission: report of two cases and review of the literature. J Infect 2000; 41:277-282.
39. Silveira F, Paterson DL. Pulmonary fungal infections. Curr Opin Pulm Med 2005; 11:242-246.
40. Cornillet A, Camus C, Nimubona S, et al. Comparison of epidemiological, clinical and biological features of invasive aspergillosis in neutropenic and nonneutropenic patients: a 6-year survey. Clin Infect Dis 2006; 43:577-584.
41. Stergiopoulou T, Meletiadis J, Roilides E, et al. Host-dependant patterns of tissue injury in invasive pulmonary aspergillosis. Am J Clin Path 2007; 127:349-355.
42. Pagano L, Ricci P, Nosari A, et al. Fatal haemoptysis in pulmonary filamentous mycosis: an underevaluated cause of death in patients with acute leukaemia in haematological complete remission. A retrospective study and review of the literature. Gimena Infection Program (Gruppo Italiano Malattie Ematologiche dell'Adulto). Br J Haematol 1995; 89:500-505.
43. Caillot D, Couaillier JF, Bernard A, et al. Increasing volume and changing characteristics of invasive pulmonary aspergillosis on sequential thoracic computed tomography scans in patients with neutropenia. J Clin Oncol 2001; 19:253-259.
44. Caillot D, Casanovas O, Bernard A, et al. Improved management of invasive pulmonary aspergillosis in neutropenic patients using early thoracic computed tomographic scan and surgery. J Clin Oncol 1997; 15:139-147.
45. Horger M, Hebart H, Einsele H, et al. Initial CT manifestations of invasive pulmonary aspergillosis in 45 non-HIV immunocompromised patients: association with patient outcome? Eur J Radiol 2007; 55:437-444.
46. Silverman ES, Mark EJ. Case records of the Massachusetts General Hospital. Weekly clinicopathological exercises. Case 36-2002. A 32-year-old man with hemoptysis of nearly three decades' duration. N Engl J Med 2002; 347:1693-1701.
47. Divate SA, Chaturvedi R, Jadhav NN, Vaideeswar P. Leptospirosis associated with diffuse alveolar haemorrhage. J Postgrad Med 2002; 48:131-132.
48. Kim EA, Lee KS, Primack SL, et al. Viral pneumonias in adults: radiologic and pathologic findings. Radiographics 2002; 22:S137-S149.
49. Magro C, Ali N, Williams JD, et al. Cytomegalovirus-associated pulmonary septal capillary injury sine inclusion body change: a distinctive cause of occult or macroscopic pulmonary hemorrage in the immunocompetent host. Appl Immunohistochem Mol Morphol 2005; 13:268-272.
50. Khalil A, Parrot A, Nedelcu K, et al. Severe hemoptysis of pulmonary arterial origin: signs and role of multidetector row CT angiography. Chest 2008; 133:212-219.
51. Khalil A, Soussan M, Mangiapan G, et al. Utility of high-resolution chest CT scan in the emergency management of haemoptysis in the intensive care unit: severity, localization and aetiology. Br J Radiol 2007; 80:21-25. The crucial role of high-resolution chest CT in diagnosing the cause and the mechanisms as well as in assessing the severity of bleeding in patients with severe haemoptysis admitted to ICU is emphasized.
52. Vernhet H, Dogas G, Bousquet C, et al. Value of thoracic CT in the management of severe hemoptysis. J Radiol 2003; 84:685-691.
53. Haponik EF, Fein A, Chin R. Managing life-threatening hemoptysis. Has anything really changed? Chest 2000; 118:1431-1435.
54. Tanaka N, Yamakado K, Murashima S, et al. Superselective bronchial artery embolization for hemoptysis with a coaxial microcatheter system. J Vasc Interv Radiol 1997; 8:65-70.
55. White RI. Bronchial artery embolotherapy for control of acute hemoptysis. Chest 1999; 115:912-915.
56. Wong ML, Szkup P, Hopley MJ. Percutaneous embolotherapy for life threatening hemoptysis. Chest 2002; 121:95-102.
57. de Gregorio MA, Medrano J, Alfonso ER, Rengel M. Endovascular treatment of massive hemoptysis by bronchial artery embolization: short-term and long-term follow-up over a 15-year period. Arch Bronconeumol 2006; 42:49-56.
58. Valipour A, Kreuzer A, Koller H, et al. Bronchoscopy-guided topical hemostatic tamponade therapy for the management of life-threatening hemoptysis. Chest 2005; 127:2113-2118.
59. MacDonald JA, Fraser JF, Foot CL, Tran K. Successful use of recombinant factor VII in massive hemoptysis due to community-acquired pneumonia. Chest 2006; 130:577-579.
60. Poyanli A, Acunas B, Rozanes I, et al. Endovascular therapy in the management of moderate and massive haemoptysis. Br J Radiol 2007; 80:331-336. This study reports the efficacy and the safety of BAE in 136 patients with moderate-to-massive haemoptysis related to tuberculosis.
61. Kim YG, Yoon HK, Ko GY, et al. Long-term effect of bronchial artery embolization in Korean patients with haemoptysis. Respirology 2006; 11: 776-781.
62. Chung MJ, Lee JH, Lee KS, et al. Bronchial and nonbronchial systemic arteries in patients with hemoptysis: depiction on MDCT angiography. AJR AM J Roentgenol 2006; 186:649-655.
63. In HS, Bae JI, Park AW, et al. Bronchial artery arising from the left gastric artery in a patient with massive haemoptysis. Br J Radiol 2006; 79:e171-e173.
64. van den Heuvel MM, Els Z, Koegelenberg CF, et al. Risk factors for recurrence of haemoptysis following bronchial artery embolisation for life-threatening haemoptysis. Int J Tuberc Lung Dis 2007; 11:909-914. Important paper analysing the rate and the causes of recurrence of haemoptysis in a large series of patients receiving BAE for severe haemoptysis related to tuberculosis.
65. Sbano H, Mitchell AW, Ind PW, Jackson JE. Peripheral pulmonary artery pseudoaneurysms and massive hemoptysis. AJR Am J Roentgenol 2004; 184:1253-1259.
66. Santelli ED, Katz DS, Goldschmidt AM, Thomas HA. Embolization of multiple Rasmussen aneurysms as a treatment of hemoptysis. Radiology 1994; 193:396-398.
67. Keeling AN, Costello R, Lee MJ. Rasmussen's aneurysm: a forgotten entity? Cardiovasc Intervent Radiol 2008; 31:196-200.
68. Picard C, Parrot A, Boussaud V, et al. Massive hemoptysis due to Rasmussen aneurysm: detection with helicoidal CT angiography and successful steel coil embolization. Intensive Care Med 2003; 29:1837-1839.
69. Bruzzi JF, Rémy-Jardin M, Delhaye D, et al. Multi-detector row CT of hemoptysis. Radiographics 2006; 26:3-22.
70. Tan LKK, Powrie DJ, Rowland R, et al. Fever and haemoptysis in an injecting drug user. Eur Respir J 2007; 29:1061-1063.
71. Endo S, Otani S, Saito N, et al. Management of massive hemoptysis in a thoracic surgical unit. Eur J Cardiothorac Surg 2003; 23:467-472.
72. Kim YT, Kang MC, Sung SW, Kim JH. Good and long-term outcomes after surgical treatment of simple and complex pulmonary aspergilloma. Ann Thorac Surg 2005; 79:294-298.
73. Caidi M, Kabiri H, Al Aziz S, et al. Surgical treatment of pulmonary aspergilloma. 278 cases. Press Med 2006; 35:1819-1824.
74. Gillet Y, Vanhems P, Lina G, et al. Factors predicting mortality in necrotizing community-acquired pneumonia caused by Staphylococcus aureus containing Panton-Valentine leukocidin. Clin Infect Dis 2007; 45:315-321. Important clinical paper strengthening the need for developing more efficaious therapy against PVL Staphylococcus aureus necrotizing pneumonia.
75. Deurenberg RH, Vink C, Driessen C, et al. Rapid detection of Panton-Valentine leukocidin from clinical isolates of Staphylococcus aureus strains by real-time PCR. FEMS Microbiol Lett 2004; 15:225-228.
76. Reischl U, Tuohy MJ, Hall GS, et al. Rapid detection of Panton-Valentine leukocidin-positive Staphylococcus aureus by real-time PCR targeting the lukS-PV gene. Eur J Clin Microbiol Infect Dis 2007; 26:131-135. Important paper on the utility for developing tests to early diagnose PVL S. aureus infection.
77. Tang YW, Kilic A, Yang Q, et al. StaphPlex system for rapid and simultaneous identification of antibiotic resistance determinants and Panton-Valentine leukocidin detection of staphylococci from positive blood cultures. J Clin Microbiol 2007; 45:1867-1873. Important paper on the utility for developing a test to diagnose PVL S. aureus infection early and assessing the profile of antibiotics resistance.
78. Flume PA, Yankaskas JR, Ebeling M, et al. Massive hemoptysis in cystic fibrosis. Chest 2005; 128:729-738.